Skip to content

Glenmark gets FDA’s nod for generic Vesicare

Glenmark Pharmaceuticals has gotten the okay from the Food and Drug Administration for solifenacin succinate tablets, in 5 mg and 10 mg dosages strengths. Solifenacin succinate tablets are the generic of Astellas Pharma’s Vesicare tablets, 5 mg and 10 mg.

BALTIMORE — Glenmark Pharmaceuticals has gotten the okay from the Food and Drug Administration for solifenacin succinate tablets, in 5 mg and 10 mg dosages strengths.

Solifenacin succinate tablets are the generic of Astellas Pharma’s Vesicare tablets, 5 mg and 10 mg.

The product had a market value of roughly $942.7 million for the 12 month period ending March 2019, according to IQVIA.

Latest

Camber offers Q1 recap

Camber offers Q1 recap

New launches emphasize Camber’s continued investment in expanding patient access to high-quality, affordable treatments.